
Similar Posts
Top SFBC officials Quit Amid Senate Inquiry Clinical Trials_ Bloomberg News
In its continuing coverage of corrupt clinical drug trial practices, Bloomberg News reports that all three founders of SFBC International, one of the largest clinical trial business operations that had failed to even screen human subjects for turberculosis, and threatened others with deportation if they refused to become guinea pigs, quit after the Senate Finance committee began investigating drug trial safety issues:
A Judicial Decision: a Victory for Open Access to Pharma Data
A Canadian Federal Court decision (July 9, 2018) is a victory not only for Dr. Peter Doshi who filed a suit to gain access to pharmaceutical data, against the Attorney General of Canada; it is a victory for “open access” and affirmation of the importance of “freedom of expression.” “Freedom…
Lancet Editor Spills the Beans and Britain’s PM Surrenders to the Gates Vaccine Cartel
Philippe Douste-Blazy, MD, a cardiologist and former French Health Minister who served as Under-Secretary General of the United Nations; he was a candidate in 2017 for Director of the World Health Organization. In a videotaped interview on May 24, 2020, Dr. Douste-Blazy provided insight into how a series of negative…
Harvard Psychiatrists Primed For a Fall
The New York Times reports that Federal prosecutors have issued a subpoena seeking information and all documents including transcripts of their testimony produced in litigation relating to three prominent Harvard researchers…
Activists Take on Eli Lilly Over Off-Label Marketing & Harm Caused by Zyprexa
The deceptive marketing of antipsychotic drugs has prompted new advocacy group to launch "The Just Say "Know" to Prescription Drugs Campaign." Its goal is to get one million people to stop and reevaluate the medications they are taking.
Ex-Head of F.D.A. Faces Criminal Inquiry
The New York Times reports that former FDA Commissioner, Dr. Lester Crawford "is under criminalo investigation by a federal grand jury over accusations of financial improprieties and false statements to Congress."